[1]林东子,王 威,邱 峰,等.基于LC-MS筛选肺结核耐药患者的血清代谢标志物[J].南方医科大学学报,2019,(12):1409-1420.[doi:10.12122/j.issn.1673-4254.2019.12.04]
 Mass spectrometry-based identification of new serum biomarkers in patients with multidrug resistant pulmonary tuberculosis[J].Journal of Southern Medical University,2019,(12):1409-1420.[doi:10.12122/j.issn.1673-4254.2019.12.04]
点击复制

基于LC-MS筛选肺结核耐药患者的血清代谢标志物()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2019年12期
页码:
1409-1420
栏目:
出版日期:
2020-01-01

文章信息/Info

Title:
Mass spectrometry-based identification of new serum biomarkers in patients with multidrug resistant pulmonary tuberculosis
作者:
林东子王 威邱 峰李玉美余晓琳林炳耀陈胤文雷春燕马 燕曾今诚周 杰
关键词:
肺结核耐药LC-MS/MS血清代谢标志物
Keywords:
pulmonary tuberculosis drug resistance LC-MS/MS serum metabolic markers
DOI:
10.12122/j.issn.1673-4254.2019.12.04
文献标志码:
A
摘要:
目的 筛选潜在可用来指示不同耐药肺结核的新型血清代谢标志物,并分析其潜在机制与功能。方法 收集结核药敏(DS)、单耐药异烟肼(MR-INH)、单耐药利福平(MR-RFP)、耐多药(MDR)和多耐药(PR)患者血清样本。有机试剂振荡、去蛋白、提取全部血清样本中的代谢物质,LC-MS/MS 技术检测全部样本中的代谢物质。Pareto-scaling 方法进行归一化,应 用 MetaboAnalyst 4.0软件进行差异分析,组间T检验,P≤0.05视为有差异的代谢物。进一步通过代谢物功能富集及共表达分析,明确差异代谢物的功能并探讨其作为标志物的意义与机制。结果 基于LC-MS/MS技术分析发现相较于DS组,MR-INH组存在286个异常表达代谢物、MR-RFP组存在362个差异代谢物、MDR组存在277个差异代谢物、PR组存在1208个差异代谢物。其中Acetylagmatine(P<0.05)、Aminopentol(P<0.05)、Tetracosanyl oleate(P<0.05)在MR-INH组中表达具有显著差异;Ala His Pro Thr(P<0.001)、Glycinoprenol-9(P<0.05)在MR-RFP组中表达差异明显;Trimethylamine(P<0.05)、Penaresidin A(P< 0.05)、Verazine(P<0.05)在MDR组中表达具有显著差异;PIP(18∶1(11Z)/18∶3(6Z,9Z,12Z))(P<0.001)、Pro Arg Trp Tyr(P< 0.001)、N-Methyldioctylamine(P<0.001)、Phytolaccoside E(P<0.05)在PR组中表达具有显著差异。与DS组相比,Phthalic acid Mono-2-ethylhexyl Ester(P<0.05)和 Eicosanoyl-EA(P<0.05)在 MR-INH、MR- RFP、MDR、PR 组均存在显著差异。结论 Acetylagmatine、Aminopentol、Tetracosanyl oleate、Ala His Pro Thr、Glycinoprenol-9、Trimethylamine、Penaresidin A、Verazine、PIP(18∶1(11Z)/18∶3(6Z,9Z,12Z))、Pro Arg Trp Tyr、N-Methyldioctylamine、Phytolaccoside E、Phthalic acid Mono-2-ethylhexyl Ester、Eicosanoyl-EA共14种新型代谢物可能是指示结核单耐药、耐多药、多耐药的潜在标志物,联合分子标志物来评估结核耐药的发生发展,可以增强诊断的灵敏度和特异性,具有一定的临床应用前景。
Abstract:
Objective To screen new serum metabolic biomarkers for different drug resistance profiles of pulmonary tuberculosis (TB) and explore their mechanisms and functions. Methods We collected serum samples from TB patients with drug sensitivity (DS), monoresistance to isoniazid (MR-INH), monoresistance to rifampin (MR-RFP), multidrug resistance (MDR), and polyresistance (PR). The metabolites in the serum samples were extracted by oscillatory and deproteinization for LC-MS/MS analysis, and the results were normalized by Pareto-scaling method and analyzed using Metaboanalyst 4.0 software to identify the differential metabolites. The differential metabolites were characterized by function enrichment and co-expression analysis to explore their function and possible pathological mechanisms. Results Compared with the DS group, 286 abnormally expressed metabolites were identified in MR-INH group, 362 in MR-RPF group, 277 in MDR group and 1208 in PR group by LC-MS/MS analysis. Acetylagmatine (P<0.05), aminopentol (P<0.05), and tetracosanyl oleate (P<0.05) in MR-INH group; Ala His Pro Thr (P<0.001) and glycinoprenol-9 (P<0.05) in MR-RFP group; trimethylamine (P<0.05), penaresidin A (P<0.05), and verazine (P<0.05) in MDR group; and PIP (18:1(11Z)/18:3(6Z,9Z,12Z)) (P<0.001), Pro Arg Trp Tyr (P<0.001), N-methyldioctylamine (P<0.001), and phytolaccoside E (P< 0.05) in PR group all showed significant differential expressions. Significant differential expressions of phthalic acid mono-2-ethylhexyl ester (P<0.05) and eicosanoyl-EA (P<0.05) were found in all the drug resistant groups as compared with DS group. Conclusion Acetylagmatine, aminopentol, tetracosanyl oleate, Ala His Pro Thr, glycinoprenol-9, trimethylamine, penaresidin A, verazine, PIP(18:1(11Z)/18:3(6Z,9Z,12Z)), Pro Arg Trp Tyr, N-methyldioctylamine, phytolaccoside E, phthalic acid mono-2-ethylhexyl ester, and eicosanoyl-EA are potentially new biomarkers that indicate monoresistance, multi-drug resistance and polyresistance of Mycobacterium tuberculosis. The combined use of these biomarkers potentially allows for assessment of drug resistance in TB and enhances the diagnostic sensitivity and specificity.

相似文献/References:

[1]耿穗娜,芮勇宇,王前,等.1017株临床分离细菌耐药谱和耐药机制的研究[J].南方医科大学学报,2005,(12):1529.
 GENG Sui-na,RUI Yong-yu,WANG Qian,et al.Analysis of drug resistance spectrum and its mechanism in 1017 clinical bacterial isolates[J].Journal of Southern Medical University,2005,(12):1529.
[2]董秋兰,魏长春,郭红革,等.50例重症肺结核合并呼吸衰竭动脉血气及电解质临床分析[J].南方医科大学学报,2004,(12):1385.
 DONG Qiu-lan,WEI Chang-chun,GUO Hong-ge,et al.Arterial blood gas and electrolytes in severe pulmonary tuberculosis with respiratory failure: analysis of 50 cases[J].Journal of Southern Medical University,2004,(12):1385.
[3]董秋兰,李艳明,吴东玲,等.肺结核住院病人延误诊断原因458例分析[J].南方医科大学学报,2004,(08):943.
 DONG Qiu-lan,LI Yan-ming,WU Dong-ling,et al.Delayed diagnosis or misdiagnosis of pulmonary tuberculosis: 458 cases clinical analysis[J].Journal of Southern Medical University,2004,(12):943.
[4]曹漫明,张积仁,汪森明,等.卵巢癌顺铂耐药细胞中DNA转录与修复相关基因的表达[J].南方医科大学学报,2005,(12):1478.
 CAO Man-ming,ZHANG Ji-ren,WANG Sen-ming,et al.Expression of DNA transcription-and repair-related genes in cisplatin-resistant human ovarian carcinoma cell line COC1/DDP[J].Journal of Southern Medical University,2005,(12):1478.
[5]亓占中,王宇亮,周向东.CA916798基因通过PI3K/AKT/mTOR通路参与顺铂耐药的机制分析[J].南方医科大学学报,2012,(09):1290.
[6]李艳,谭守勇,罗春明,等.依赖利福平与耐利福平结核杆菌肺结核的临床特点比较[J].南方医科大学学报,2013,(02):287.
[7]曾爱红,董德坤,崔喜梅,等.造血干细胞移植后巨细胞病毒药敏检测及UL97基因突变分析[J].南方医科大学学报,2014,(04):519.
[8]劳穗华,王娟,俞朝贤,等.肺结核并重症肺炎行有创机械通气患者下呼吸道病原菌分布及耐药性特点[J].南方医科大学学报,2014,(08):1192.
[9]李贝贝,董淑英,樊宗兵,等.两种方法建立的睾丸癌顺铂耐药细胞株的比较[J].南方医科大学学报,2015,(12):1755.
[10]陈瀛,郑克鸿,陈泽涛,等.干扰ADAM17表达可降低人结肠癌细胞对西妥昔单抗耐药[J].南方医科大学学报,2018,(11):1366.[doi:10.12122/j.issn.1673-4254.2018.11.15]

更新日期/Last Update: 2019-12-27